Multiple models testing prediction of long-term outcomes by serum ferritin combined with NFS to predict long-term outcomes
Method | Liver-related events (93/1179) | HCC (22/1177) | Cardiovascular events (123/1117) | Extrahepatic cancer (84/981) | Mortality (60/1189) |
Cox regression | 0.723±0.009* | 0.885±0.002 | 0.682±0.005 | 0.604±0.001 | 0.65±0.02* |
Lasso-penalised Cox regression | 0.722±0.009* | 0.884±0.003* | 0.689±0.004 | 0.604±0.001 | 0.63±0.012* |
Ridge-penalised Cox regression | 0.722±0.009* | 0.885±0.002 | 0.682±0.007 | 0.599±0.002 | 0.636±0.015* |
Elastic net-penalised Cox regression | 0.722±0.008* | 0.884±0.002 | 0.689±0.004 | 0.603±0.001 | 0.63±0.011* |
Median Harrell’s C-indices with corresponding standard errors of the median estimated on the test sets of the cross-validation. Cox proportional hazard models and its penalised variants (i.e., Lasso, Ridge and Elastic Net) were applied. The ratio number of events/total number for each outcome is reported on top into brackets.
*Reporting statistically higher C-indices with respect to the same model tested on the same cross-validation split but considering only confounders, according to the one-sided Wilcoxon signed rank test (p value <0.05).
†P value <0.1 on the same test.
HCC, hepatocellular carcinoma; NFS, NAFLD Fibrosis Score.